Assessment of Monitoring and Management Practices of Antipsychotic-Induced Hyperprolactinemia at a Medical City in Riyadh, Saudi Arabia: A Retrospective Cohort Study

Journal: Curr Drug Saf

Publication date: 2024

Journal: Curr Drug Saf

Publication Year: 2024

Authors & Co-authors: 

Differential protection of black-seed oil on econucleotidase, cholinesterases and aminergic catabolizing enzyme in haloperidol-induced neuronal damage of male rats

Journal: Ther Adv Drug Saf

Publication date: 2016

Journal: Ther Adv Drug Saf

Publication Year: 2016

Authors & Co-authors: 

Maternal and Early-Life Exposure to Antibiotics and the Risk of Autism and Attention-Deficit Hyperactivity Disorder in Childhood: a Swedish Population-Based Cohort Study

Journal: Drug Saf

Publication date: 2023

Journal: Drug Saf

Publication Year: 2023

Authors & Co-authors: 

Adverse events with pemigatinib in the real world: a pharmacovigilance study based on the FDA Adverse Event Reporting System.

Journal: Expert opinion on drug safety

Publication date: 

Journal: Expert opinion on drug safety

Publication Year: 

Authors & Co-authors:  Zhao Long Wang

Assessment of Monitoring and Management Practices of Antipsychotic-Induced Hyperprolactinemia at a Medical City in Riyadh, Saudi Arabia: A Retrospective Cohort Study.

Journal: Current drug safety

Publication date: 

Journal: Current drug safety

Publication Year: 

Authors & Co-authors:  Alshabeeb Alsuwayni Alshargi Abdelazeem

Differential protection of black-seed oil on econucleotidase, cholinesterases and aminergic catabolizing enzyme in haloperidol-induced neuronal damage of male rats.

Journal: Therapeutic advances in drug safety

Publication date: 2016

Journal: Therapeutic advances in drug safety

Publication Year: 2016

Authors & Co-authors:  Akintunde Jacob K JK Irechukwu C Abigail CA

Selective serotonin reuptake inhibitors, post-treatment sexual dysfunction and persistent genital arousal disorder: A systematic review.

Journal: Pharmacoepidemiology and drug safety

Publication date: 2023

Journal: Pharmacoepidemiology and drug safety

Publication Year: 2023

Authors & Co-authors:  Tarchi Livio L Merola Giuseppe Pierpaolo GP Baccaredda-Boy Ottone O Arganini Francesca F Cassioli Emanuele E Rossi Eleonora E Maggi Mario M Baldwin David S DS Ricca Valdo V Castellini Giovanni G

Maternal and Early-Life Exposure to Antibiotics and the Risk of Autism and Attention-Deficit Hyperactivity Disorder in Childhood: a Swedish Population-Based Cohort Study.

Journal: Drug safety

Publication date: 2023

Journal: Drug safety

Publication Year: 2023

Authors & Co-authors:  Njotto Lembris L LL Simin Johanna J Fornes Romina R Odsbu Ingvild I Mussche Isabelle I Callens Steven S Engstrand Lars L Bruyndonckx Robin R Brusselaers Nele N

Anticholinergic burden among in-patients: a cross-sectional study on prevalence, determinants, and impact on mortality in Ethiopia.

Journal: Therapeutic advances in drug safety

Publication date: 

Journal: Therapeutic advances in drug safety

Publication Year: 

Authors & Co-authors:  Gebreyohannes Eyob Alemayehu EA Taye Wagaye Atalay WA Shibe Biniam Siyum BS Ayele Emneteab Mesfin EM Lee Kenneth K Mengistu Segenet Bizuneh SB Soiza Roy Louis RL Myint Phyo Kyaw PK Abdela Ousman Abubeker OA